相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structurally Enabled Discovery of Adenosine A2A Receptor Antagonists
Ali Jazayeri et al.
CHEMICAL REVIEWS (2017)
Allostery and Biased Agonism at Class B G Protein-Coupled Receptors
Denise Wootten et al.
CHEMICAL REVIEWS (2017)
Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status
Hilda Ferrero et al.
CNS DRUGS (2017)
Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146
G. R. Kolar et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Cornerstones of CRISPR-Cas in drug discovery and therapy
Christof Fellmann et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial
Jeremy Veenstra-VanderWeele et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Open Targets: a platform for therapeutic target identification and validation
Gautier Koscielny et al.
NUCLEIC ACIDS RESEARCH (2017)
Alignment-free d2* oligonucleotide frequency dissimilarity measure improves prediction of hosts from metagenomically-derived viral sequences
Nathan A. Ahlgren et al.
NUCLEIC ACIDS RESEARCH (2017)
Commensal bacteria make GPCR ligands that mimic human signalling molecules
Louis J. Cohen et al.
NATURE (2017)
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
Catherine J. Hutchings et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
2016 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2017)
Angiotensin II for the Treatment of Vasodilatory Shock
Ashish Khanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Allosteric beta-blocker isolated from a DNA-encoded small molecule library
Seungkirl Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
How Ligands Illuminate GPCR Molecular Pharmacology
Daniel Wacker et al.
CELL (2017)
G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges
Kurt Ritter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks
Qiancheng Shen et al.
NUCLEIC ACIDS RESEARCH (2016)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
Christopher Southan et al.
NUCLEIC ACIDS RESEARCH (2016)
GPCRdb: an information system for G protein-coupled receptors
Vignir Isberg et al.
NUCLEIC ACIDS RESEARCH (2016)
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
Uwe K. Zettl et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Editorial overview: New technologies: GPCR drug design and function - exploiting the current (of) structures
Christofer S. Tautermann et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
Michael Nauck et al.
DIABETES CARE (2016)
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
Paul D. Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
In vivo veritas, the next frontier for functionally selective GPCR ligands
Jean Martin Beaulieu
METHODS (2016)
PHARMACOLOGY Inside-out receptor inhibition
Thomas P. Sakmar et al.
NATURE (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
G protein-coupled receptors as targets for anti-diabetic therapeutics
Da Young Oh et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
A randomized, phase 2 study investigating TRV130, a biased ligand of the mu-opioid receptor, for the intravenous treatment of acute pain
Eugene R. Viscusi et al.
PAIN (2016)
Recent updates on GPCR biased agonism
Andre S. Pupo et al.
PHARMACOLOGICAL RESEARCH (2016)
Dopaminergic drugs in type 2 diabetes and glucose homeostasis
Felicitas Lopez Vicchi et al.
PHARMACOLOGICAL RESEARCH (2016)
Polypharmacology of dopamine receptor ligands
S. Butini et al.
PROGRESS IN NEUROBIOLOGY (2016)
Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases
James L. Richards et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
G Protein-Coupled Receptor Signaling in Stem Cells and Cancer
Jennifer R. Lynch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
A Pluridimensional View of Biased Agonism
Claudio M. Costa-Neto et al.
MOLECULAR PHARMACOLOGY (2016)
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
Chris de Graaf et al.
PHARMACOLOGICAL REVIEWS (2016)
G Protein-Coupled Receptors in Cancer
Rachel Bar-Shavit et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
New paradigms in GPCR drug discovery
Kenneth A. Jacobson
BIOCHEMICAL PHARMACOLOGY (2015)
Metabotropic glutamate receptors as drug targets: what's new?
Ferdinando Nicoletti et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Nanobodies and their Use in GPCR Drug Discovery
Karen D. Cromie et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
GPR40 agonists for the treatment of type 2 diabetes: life after 'TAKing' a hit
A. D. Mancini et al.
DIABETES OBESITY & METABOLISM (2015)
Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial
K. Kaku et al.
DIABETES OBESITY & METABOLISM (2015)
Structures of G protein-coupled receptors reveal new opportunities for drug discovery
Robert M. Cooke et al.
DRUG DISCOVERY TODAY (2015)
Chemokine receptors as therapeutic targets: Why aren't there more drugs?
Roberto Solari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Galanin receptors as a potential target for neurological disease
Krista Freimann et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Biased Agonism of the Angiotensin II Type I Receptor A Potential Strategy for the Treatment of Acute Heart Failure
Yuichi Ikeda et al.
INTERNATIONAL HEART JOURNAL (2015)
Novel Therapeutic GPCRs for Psychiatric Disorders
Hidetoshi Komatsu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Recognition of Bacterial Signal Peptides by Mammalian Formyl Peptide Receptors A NEW MECHANISM FOR SENSING PATHOGENS
Bernd Bufe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
From G Protein-coupled Receptor Structure Resolution to Rational Drug Design
Ali Jazayeri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Gut chemosensing mechanisms
Arianna Psichas et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Insights into bombesin receptors and ligands: Highlighting recent advances
Irene Ramos-Alvarez et al.
PEPTIDES (2015)
Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth
Nella Prevete et al.
PHARMACOLOGICAL RESEARCH (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors
Ikuo Masuho et al.
SCIENCE SIGNALING (2015)
Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors
Ikuo Masuho et al.
SCIENCE SIGNALING (2015)
Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity
Roland Lang et al.
PHARMACOLOGICAL REVIEWS (2015)
A Molecular Pharmacologist's Guide to G Protein-Coupled Receptor Crystallography
Chayne L. Piscitelli et al.
MOLECULAR PHARMACOLOGY (2015)
International Union of Basic and Clinical Pharmacology. XCV. Recent Advances in the Understanding of the Pharmacology and Biological Roles of Relaxin Family Peptide Receptors 1-4, the Receptors for Relaxin Family Peptides
Michelle L. Halls et al.
PHARMACOLOGICAL REVIEWS (2015)
International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G Protein-Coupled Receptors
Joerg Hamann et al.
PHARMACOLOGICAL REVIEWS (2015)
The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication
Mathias Rask-Andersen et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Use of Antidiabetic Drugs in the U. S., 2003-2012
Christian Hampp et al.
DIABETES CARE (2014)
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefania Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Polypharmacology: Challenges and Opportunities in Drug Discovery
Andrew Anighoro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Development of allosteric modulators of GPCRs for treatment of CNS disorders
Hilary Highfield Nickols et al.
NEUROBIOLOGY OF DISEASE (2014)
DrugBank 4.0: shedding new light on drug metabolism
Vivian Law et al.
NUCLEIC ACIDS RESEARCH (2014)
Extrasensory perception: Odorant and taste receptors beyond the nose and mouth
Simon R. Foster et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Biased ligands at G-protein-coupled receptors: promise and progress
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Allosteric and biased G protein-coupled receptor signaling regulation: potentials for new therapeutics
Etienne Khoury et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
Arthur Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2014)
The Dynamic Process of β2-Adrenergic Receptor Activation
Rie Nygaard et al.
CELL (2013)
Emerging paradigms in GPCR allostery: implications for drug discovery
Denise Wootten et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Tools for GPCR drug discovery
Ru Zhang et al.
ACTA PHARMACOLOGICA SINICA (2012)
G protein-coupled receptors as therapeutic targets for multiple sclerosis
Changsheng Du et al.
CELL RESEARCH (2012)
Trends in the exploitation of novel drug targets
Mathias Rask-Andersen et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
G protein-coupled receptors: novel targets for drug discovery in cancer
Rosamaria Lappano et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The role of G protein-coupled receptors in the pathology of Alzheimer's disease
Amantha Thathiah et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Sudarshan Rajagopal et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The therapeutic potential of G-protein coupled receptors in Huntington's disease
Megan J. Dowie et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Anatomical Profiling of G Protein-Coupled Receptor Expression
Jean B. Regard et al.
CELL (2008)
GPR119: Double-dipping for better glycemic control
L. Lauffer et al.
ENDOCRINOLOGY (2008)
Opinion - How many drug targets are there?
John P. Overington et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The GRAFS classification system of G-protein coupled receptors in comparative perspective
HB Schiöth et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2005)
Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug
R Capdeville et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
G-protein-coupled receptors and signaling networks: emerging paradigms
MJ Marinissen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Bombesin-like peptides: studies on food intake and social behaviour with receptor knock-out mice
K Yamada et al.
ANNALS OF MEDICINE (2000)
分享论文
